Stock Ratings / Health Care / PHVS / options

RCUS (19) PBH (60) HCM (42) PGEN (32) ⌘ Pro Terminal →

Pharvaris N.V. (PHVS) Options Positioning, Max Pain & Unusual Sweeps

$33.58 +2.32% NASDAQ • Live Quote vs Prior Daily Close (Synced Snapshot) EXT / AFTER-HRS: $33.66

Pharvaris N.V. (PHVS) carries a Roarable Rating of C- (Hold) with 59/100 RQD Confidence. The composite score sits in the neutral Hold band (59–69), meaning current holders don’t need to panic-sell while prospective buyers can wait for a move into the 70+ Buy zone.

📊 Historical Track Record: Scores of 59/100 (C-) historically posted market-perform odds over rolling 90-day windows (+0.2% avg 90D alpha vs SPY) →

ROARABLE C- • HOLD / WATCH Cap $2.34B

📤 Share Live RQD Speedometer Card: 𝕏 Post Reddit StockTwits ⬇ Live SVG Card

⚡ INSTANT AI QUANT PREVIEW • $0 FREE TIER Click Any Pre-Computed AI Quant Specialist Briefing on PHVS Below — or Connect Your Own ChatGPT / Claude

🤖 Mara Quenwick • AI Quant Lead (Click for Instant Brief) Is PHVS stock a Buy, Hold, or Sell right now according to Roarable's RQD model?

▼

As of 2026-11-02, Pharvaris N.V. (NASDAQ: PHVS) is rated C- (Hold / HOLD) by Roarable's 5-pillar RQD engine with a composite confidence score of 59/100 at a spot price of $33.58 (+2.32% 1D, market cap $2.34B). Pillar breakdown: Fundamental Cash Engine 12/20, Institutional 13F & Options Flow 12/20, Executive Insider Alignment 13/20, FRED Macro Regime Fit 13/20, and SEC Balance-Sheet Forensics 9/20. Across 1016 tracked Health Care issuers, PHVS ranks #184 in composite RQD confidence.

✓ Pre-computed one-to-many AI Quant brief

🤖 Ellis Vennor • AI Peer & Flow Quant (Click for Instant Brief) How does PHVS compare to RCUS and PBH in the Health Care sector?

▼

Within the Health Care sector (Biotechnology: Pharmaceutical Preparations), PHVS carries a Roarable C- (59/100 RQD), trailing P/E of N/A, gross margin of —, and ROIC of —. By comparison, RCUS (Arcus Biosciences Inc.) holds a E grade (19/100 RQD, P/E N/A, ROIC -35.0%, cap $2.37B) and PBH (Prestige Consumer Healthcare Inc.) posts a C- grade (60/100 RQD, P/E 12.1x, ROIC 13.8%, cap $2.31B). Among the 5-stock peer group, HCM leads on earnings multiple (5.2x) while PBH leads on capital efficiency (13.8% ROIC).

✓ Pre-computed one-to-many AI Quant brief

🤖 Gideon Ashmere • AI SEC 10-K Forensics (Click for Instant Brief) What are the biggest fundamental strengths and SEC risk factors for PHVS?

▼

For Pharvaris N.V. (PHVS), key quantitative strengths include Established market leader in Health Care with deep daily trading liquidity. and sector rank #184 in Health Care, while primary risk factors center on Company executives have done more routine share selling than personal cash buying lately. and implied 5-year growth hurdle of 8.0%/yr. Institutional options positioning shows a 50% call / 50% put premium split.

✓ Pre-computed one-to-many AI Quant brief

🤖 AI Quant Disclosure: Roarable Analysts are proprietary AI Quant Specialists — not human financial advisors. Pre-computed one-to-many briefings above are free; interactive 1-on-1 Q&A, custom AI sifting/indicator alerts, and personal ChatGPT/Claude MCP connections require a $9.95/mo Pro account (currently waitlist-only).

INTERACTIVE SCENARIO DECK:

🛡️ Portfolio Crash X-Ray

EXT / AFTER-HRS: $33.66 (+0.23%)🧬 Disciplined Float (-0.40% YoY Shares)⚙️ Cash Engine: 12/20 (C-) • 1.6% FCF Margin

Verify 90D Bucket Audit →

📊 Historical Track Record: Scores of 59/100 (C-) historically posted market-perform odds over rolling 90-day windows (+0.2% avg 90D alpha vs SPY • 53.1% hit rate — wait for RQD ≥ 70 breakout).

Audit Bucket Track Record →

RQD QUANT TACHOMETERHOLD / WATCH • C-

JEV AI Jury Split (Battleground)

Cash

SEC

Whale

Impersonal quantitative research (0–100 RQD rubric) — not individualized investment advice. Past performance does not guarantee future results. Full Disclaimer

5-PILLAR SNOWFLAKE RADARRw D+ · Rk C

Each axis scored 0–20

12M PRICE TARGET CONE+0.4% Base Target

WHALE OPTIONS SNAPSHOT: — (No Active Options Snapshot on file for PHVS)Realized 20D OHLCV Swing Band: ±8.9%

Deterministic 5-Pillar Attribution (59/100 Composite)

🔍 WHY PHVS SCORES 59/100 (C-) — TOP 3 DRIVERS2 Bullish Pillars + #1 Risk Drag

▲ #1 Bullish Driver: SEC 10-K Forensic Risk+13/20 pts (22% of score)

Altman Z-Score 3.80 (FORTRESS SAFE (>3.0)) • Piotroski F-Score 7/9

▲ #2 Bullish Driver: Macro Regime Fit+13/20 pts (22% of score)

FRED Regime × Technicals: 57% of 52W Range • RSI-14 at 59.8 (BULLISH MOMENTUM)

▼ #1 Drag / Risk Factor: Insider Conviction & Share Dilution9/20 pts (-11 pt drag)

Disciplined Float (-0.40% YoY Shares) & executive Form 4 sales trim 11 pts from alignment

📈 PAST 4 QUARTERS RQD vs SUBSEQUENT RETURNQ1 → Q2 → Q3 → Current

Q1 (-3Q)

Grade C-$30.89-3.6% Next Q

Q2 (-2Q)

Grade C-$29.77+5.9% Next Q

Q3 (-1Q)

Grade C$31.54+6.5% Next Q

Current

Grade C-$33.58+0.2% Hist 90D α

Trajectory: C- (51) → C- (59)Full Audit →

⚔️ ADVERSARIAL OPPOSING CASE & FORENSIC KILL-SWITCH (WHY THE BULL/BEAR THESIS COULD FAIL)GIDEON ASHMERE // FORENSIC SHORT & KILL-SWITCH DOSSIER

⚔️ Adversarial Opposing Case: Why the PHVS Bull Thesis Could Fail

Gideon Ashmere Forensic Desk →

Even with a 59/100 (C-) score, PHVS faces multiple-compression risk if current valuation multiples re-rate toward historical sector medians or if hyperscaler/enterprise customer concentration slows in upcoming 10-Q filings.

⚠️ Forensic Kill-Switch #1

Company executives have done more routine share selling than personal cash buying lately.

⚠️ Forensic Kill-Switch #2

Dilution & Margin Drag: Disciplined Float (-0.40% YoY Shares) — any gross margin slip below 49.5% triggers an automatic RQD downgrade.

⚠️ Forensic Kill-Switch #3

Technical & Forensic Kill-Switch: A daily close below the 50D SMA ($33.61) or 200D SMA ($31.04) invalidates the momentum regime and cuts Target Base ($33.73) toward Bear Floor ($26.31).

🎲 LIVE PREDICTION MARKET ODDS TIED TO $PHVS• $2.4M Crowd Pool • Kalshi / Polymarket Composite

Contract: “PHVS Beats Next Quarter EPS Consensus (Upcoming Quarter) & Holds Above 200D SMA”

YES 59%NO 41%Trade / Inspect Odds →

CALL VS. PUT WHALE SHARE

— (No Active Options Snapshot)

Put/Call Ratio: — (No Active Options Snapshot)

MAX-PAIN EXPIRATION MAGNET

— (No Active Options Snapshot)

No active options chain max-pain snapshot on file

HISTORICAL 20D VOLATILITY SWING

±8.9%

Derived from 20D OHLCV bars (No Active Options Snapshot)

Active Strike Call vs. Put Concentration Ladder (PHVS)

— (No Active Options Snapshot) — No unusual CBOE strike concentration anomalies recorded in the current database snapshot for PHVS.

Sponsored / Partner SpotlightACTIVE TRADER & PROP EVALUATION DESK

Practice in Our Weekly $100,000 Paper Arena Before Risking Personal Capital

Keep your personal nest egg in cash while trading NQ, ES, Crude, and Gold momentum using institutional prop-desk buying power.

FTC Disclosure: Roarable may receive partner referral compensation at no cost to you. Partner relationships never influence RQD scores.

🏆 Enter Free $100K Paper Arena →

ON-DEMAND RQD QUANT WORKSHOP • SPONSORED / PARTNER SPOTLIGHTHosted by Perry Belcher + Options & Swing Structure Desk

Whale Flow & Momentum Playbook: Evaluating PHVS & AI Leaders Without Chasing Tops

✓Institutional whale strikes & implied earnings move audit on PHVS
✓How disciplined traders manage risk using pre-published trigger & invalidation levels
✓Includes nightly RQD rating-change & forensic signal email alerts on tracked leaders

RQD INSIDER CLUB WAITLIST$49/YR PLANNED

Want Custom AI PineScript / Python Indicators & Priority Rating-Change Alerts?

Join Founding VIP Waitlist (No Card Required) →$100K Arena

PHVS // CANDLESTICK & AUTO-TRENDLINE WORKSTATION6M: +11.86%📐 HORIZONTAL RANGE

2026-11-02O $32.82H $33.58L $32.82C $33.58VOL 879.1K

RES: $48.09SUP: $26.89SMA50: $33.61SMA200: $31.04

PRIMARY-SOURCE FORENSICS, SECOND-ORDER LINKS & AI ANALYST DESK

PHVS Dilution Monitor, Expectations Hurdle, Butterfly Connections & Policy Exposure

🦋 PHVS Butterfly Map → + Track PHVS →

Share Count & Dilution Monitor (#25)

Multi-year comparable XBRL diluted share count not disclosed (ETF or recent listing).

Reverse-DCF Expectations Hurdle (#30)

8.0%/yr Implied 5Y Growth

vs. +6.0% actual YoY revenue growth (assuming 9.25% cost of equity & 16.5x terminal multiple).

Ellis Vennor Setup Ledger (#33)

No active Ellis Vennor swing setup published on PHVS today. View full Setup Ledger →

🦋 Documented & Second-Order Butterfly Connections Open Graph →

No direct multi-tier Butterfly edges indexed yet for PHVS. Explore sector supply chains on /butterfly.

AI Analyst Theses, Washington Policy & Company Video

🎬 No recent verified company-specific video clip queued for PHVS today (we never pad ticker pages with unrelated generic clips). Browse Macro Video Desk →

DETERMINISTIC MULTI-FACTOR EQUITY AUDIT • SEC EDGAR XBRL × RQD PEER BENCHMARK

📊 Quantitative Sector Peer Comparison, SEC Filing Delta & Investment FAQ (PHVS)

Health Care Rank #184 of 1016 ⚔️ RCUS vs PHVS Full Matrix →

1. Head-to-Head Health Care Peer Comparison (PHVS vs. RCUS, PBH, HCM, PGEN)

Industry: Biotechnology: Pharmaceutical Preparations (489 Tracked Issuers)

Across 1016 tracked Health Care securities in the Roarable RQD universe, Pharvaris N.V. (PHVS) ranks #184 by composite RQD confidence (59/100, grade C-) and #232 by equity capitalization ($2.34B). Within this direct 5-issuer industry benchmark cohort, HCM leads on earnings valuation at 5.2x trailing P/E, while PBH leads on capital efficiency and profitability with 13.8% ROIC and 54.7% gross margin. PBH currently holds the highest overall quantitative score in the immediate peer group at 60/100 (C-) compared with PHVS at 59/100 (C-).

Ticker / Company	Roarable Grade	RQD Score	Trailing P/E	Gross Margin	ROIC	1D Change	Market Cap	Head-to-Head
PHVS ACTIVE Pharvaris N.V.	C-	59/100	—	—	—	+2.32%	$2.34B	Benchmark Subject
RCUS Arcus Biosciences Inc.	E	19/100	—	—	-35.0%	+1.20%	$2.37B	/rcus-vs-phvs →
PBH Prestige Consumer Healthcare Inc.	C-	60/100	12.1x	54.7%	13.8%	+2.01%	$2.31B	/pbh-vs-phvs →
HCM HUTCHMED (China) Limited	D-	42/100	5.2x	—	-2.5%	+2.03%	$2.37B	/hcm-vs-phvs →
PGEN Precigen Inc.	E	32/100	—	—	-35.0%	+9.21%	$2.38B	/pgen-vs-phvs →

2. PHVS Fundamental Profitability, Capital Efficiency & Balance-Sheet Forensics

TRAILING 12M & FORWARD QUANTITATIVE SNAPSHOT

Pharvaris N.V. (PHVS) operates in Biotechnology: Pharmaceutical Preparations (Health Care) with an equity capitalization of $2.34B, trailing P/E of N/A, forward P/E of N/A, and EV/EBITDA of N/A. Operating profitability registers a gross margin of —, operating margin of —, net profit margin of —, ROIC of —, and free cash flow yield of —, alongside an Altman Z-Score of N/A and Piotroski F-Score of N/A.

3. PHVS Data-Verified Investor FAQ (RQD Rating, Sector Peers, SEC Forensics & Technicals)

✓ SCHEMA.ORG FAQPAGE JSON-LD ENABLED

Is PHVS stock a Buy, Hold, or Sell right now according to Roarable's RQD model?

How does PHVS compare to RCUS and PBH in the Health Care sector?

What are the biggest fundamental strengths and SEC risk factors for PHVS?

Where is PHVS trading relative to its 50-day, 200-day, and 52-week technical levels?

PHVS last traded at $33.58 (+2.32% on volume of 879,103 shares), positioning the stock -0.09% below its 50-day simple moving average ($33.61) and +8.18% above its 200-day simple moving average ($31.04). Across its 52-week range of $21.02 to $43.25, PHVS sits at the 56.5% percentile with a 14-day RSI of 59.8 (BULLISH MOMENTUM) and an implied next-earnings move of ±8.9% ($30.59 to $36.57).

PHVS Investor FAQ & Complete 8-Part Research Index

100% OPEN ACCESS • SEC EDGAR × CBOE × FRED

What is PHVS's options positioning and volatility profile?

Roarable tracks verified CBOE unusual options sweeps, put/call ratios, and OHLCV realized volatility bands for PHVS.

Direct Sub-Reports: PHVS RQD Cockpit PHVS 12M Forecast PHVS Earnings & Move PHVS Dividends & DRIP PHVS Insiders & 13F PHVS Whale Options PHVS Profit Sankey PHVS News & Why